110 related articles for article (PubMed ID: 6533499)
21. Radiolabeled monoclonal antibodies for the diagnosis and treatment of ovarian carcinoma.
Wahl RL
Front Radiat Ther Oncol; 1990; 24():228-39. PubMed ID: 2187760
[No Abstract] [Full Text] [Related]
22. Monoclonal antibody imaging of colorectal and ovarian cancer.
Haseman MK
West J Med; 1994 Oct; 161(4):412. PubMed ID: 7817555
[No Abstract] [Full Text] [Related]
23. Intraoperative radioimmunodetection of ovarian cancer using monoclonal antibody B72.3 and a portable gamma-detecting probe.
Bell J; Mojzisik C; Hinkle G; Derman H; Schlom J; Martin E
Obstet Gynecol; 1990 Oct; 76(4):607-11. PubMed ID: 2216188
[TBL] [Abstract][Full Text] [Related]
24. Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy.
Granowska M; Nimmon CC; Britton KE; Crowther M; Mather SJ; Slevin ML; Shepherd JH
J Nucl Med; 1988 May; 29(5):599-607. PubMed ID: 3373302
[TBL] [Abstract][Full Text] [Related]
25. Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours.
Epenetos AA; Britton KE; Mather S; Shepherd J; Granowska M; Taylor-Papadimitriou J; Nimmon CC; Durbin H; Hawkins LR; Malpas JS; Bodmer WF
Lancet; 1982 Nov; 2(8306):999-1005. PubMed ID: 6127540
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody.
Crippa F; Buraggi GL; Di Re E; Gasparini M; Seregni E; Canevari S; Gadina M; Presti M; Marini A; Seccamani E
Eur J Cancer; 1991; 27(6):724-9. PubMed ID: 1829912
[TBL] [Abstract][Full Text] [Related]
27. [Visualization of malignant tumors in the abdomen using radiolabelled monoclonal antibodies].
Pateisky N; Philipp K; Burchell J; Skodler W
Geburtshilfe Frauenheilkd; 1984 Oct; 44(10):623-6. PubMed ID: 6097499
[TBL] [Abstract][Full Text] [Related]
28. Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours.
Granowska M; Mather SJ; Jobling T; Naeem M; Burchell J; Taylor-Papadimitriou J; Shepherd J; Britton KE
Int J Biol Markers; 1990; 5(2):89-96. PubMed ID: 2283483
[TBL] [Abstract][Full Text] [Related]
29. Immunopharmacokinetics of 111In-CYT-103 in ovarian cancer patients.
Jusko WJ; Kung LP; Schmelter RF
Targeted Diagn Ther; 1992; 6():177-90. PubMed ID: 1576345
[No Abstract] [Full Text] [Related]
30. Radioimmunoscintigraphy of ovarian tumors using a new monoclonal antibody, SM-3.
Jobling TW; Granowska M; Britton KE; Lowe DG; Mather SJ; Burchell J; Naeem M; Shepherd JH
Gynecol Oncol; 1990 Sep; 38(3):468-72. PubMed ID: 2227563
[TBL] [Abstract][Full Text] [Related]
31. Impact of 111In-CYT-103 on the surgical management of patients with ovarian cancer.
Surwit EA
Targeted Diagn Ther; 1992; 6():125-40. PubMed ID: 1576343
[No Abstract] [Full Text] [Related]
32. Generation and characterization of three monoclonal antibodies to human ovarian epithelial adenocarcinomas.
Qian HN; Feng J; Cui H; Fu TY; Wei P; Fu ZY
Chin Med J (Engl); 1989 Nov; 102(11):839-43. PubMed ID: 2517724
[TBL] [Abstract][Full Text] [Related]
33. A preliminary study of radioimmunoimaging by 131I-COC183B2 monoclonal antibody in patients with epithelial ovarian cancer.
Qian HN; Feng J; Cui H; Gao BS; Qin SL; Fu TY; Wei P; Fu ZY; Gao SM; Yang ZY
Chin Med J (Engl); 1991 Feb; 104(2):109-13. PubMed ID: 1874008
[TBL] [Abstract][Full Text] [Related]
34. Radioimmunoscintigraphy using monoclonal antibodies before second-look surgery in patients suffering from ovarian cancer.
Pateisky N; Philipp K; Sevelda P; Skodler WD; Enzelsberger H; Hamilton G; Burchell J; Schatten C
Gynecol Obstet Invest; 1987; 24(3):211-6. PubMed ID: 3692333
[TBL] [Abstract][Full Text] [Related]
35. [Value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and follow-up of primary ovarian carcinoma].
Barzen G; Cordes M; Langer M; Friedman W; Mayr AC; Felix R
Rofo; 1990 Jul; 153(1):85-91. PubMed ID: 2166319
[TBL] [Abstract][Full Text] [Related]
36. 5-123I/125I-iodo-2'-deoxyuridine for cancer diagnosis and therapy.
Kassis AI
J Nucl Med Allied Sci; 1990; 34(4):299-303. PubMed ID: 2090794
[No Abstract] [Full Text] [Related]
37. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125.
Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M
Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745
[TBL] [Abstract][Full Text] [Related]
38. Radioimmunodetection in patients with suspected ovarian cancer.
Pateisky N; Philipp K; Skodler WD; Czerwenka K; Hamilton G; Burchell J
J Nucl Med; 1985 Dec; 26(12):1369-76. PubMed ID: 4067639
[TBL] [Abstract][Full Text] [Related]
39. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
[TBL] [Abstract][Full Text] [Related]
40. Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies.
Malamitsi J; Skarlos D; Fotiou S; Papakostas P; Aravantinos G; Vassilarou D; Taylor-Papadimitriou J; Koutoulidis K; Hooker G; Snook D
J Nucl Med; 1988 Dec; 29(12):1910-5. PubMed ID: 3193206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
